Arvinas, Inc. (ARVN)
9.89
-0.33
(-3.23%)
USD |
NASDAQ |
Apr 29, 10:00
Arvinas Research and Development Expense (TTM) : 282.90M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.25B |
| EyePoint, Inc. | 221.04M |
| Apellis Pharmaceuticals, Inc. | 295.85M |
| Elanco Animal Health, Inc. | 368.00M |
| Gossamer Bio, Inc. | 174.07M |